Elevated HMGB1 promotes the malignant progression and contributes to cisplatin resistance of non-small cell lung cancer

Table 2 The clinicopathological features of all NSCLC patients

Characteristic	Numbers	HMGB1 (µg/L)	P value
Age, years			0.306
≤ 55	17	29.30 ± 12.01
> 55	29	24.99 ± 9.82
Sex			0.471
Male	27	23.69 ± 10.16
Female	21	26.92 ± 12.13
Smoking			0.103
Yes	27	27.96 ± 12.35
No	19	24.40 ± 10.46
Types			0.016
Adenocarcinoma	38	28.59 ± 10.71
Squamous cell carcinoma	8	19.54 ± 12.08

ISSN: 1601-5223